Ocean BiomedicalOCEA

13F holders, Q2 2025 (June 30)
6holders −17
2new positions
20sold out
$0.01avg. 13F price*

At the end of Q2 2025, 6 institutions reported holding Ocean Biomedical Inc. (OCEA) in their 13F filings, down 17 from Q1 2025. 2 opened new positions and 20 sold out. The largest holders were XTX Topco Ltd ($3K), Vanguard Personalized Indexing Management, LLC ($2K) and Baader Bank Aktiengesellschaft ($278).

Company
Ocean Biomedical Inc.
CUSIP
67644C104
Latest filing quarter
Q2 2026

History

Number of 13F holders

01020304050 Q1 2024: 43Q1 2024Q2 2024: 35Q2 2024Q3 2024: 20Q3 2024Q4 2024: 21Q4 2024Q1 2025: 23Q1 2025Q2 2025: 6Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions2$3K
Exits20$232K

All 13F filers, Q1 2025 → Q2 2025: 516,163 shares bought and 4,348,202 shares sold, net −3,832,039 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

XTX Topco Ltd 0.00% New 421,021 $3K
Vanguard Personalized Indexing Management, LLC 0.00% Add +19.2% 310,445 $2K
Baader Bank Aktiengesellschaft 0.00% Add +129.6% 61,525 $278
Sage Mountain Advisors LLC 0.00% New 10,464 $76
Simplex Trading, LLC 0.00% Reduce -37.1% 8,133 $0
FNY Investment Advisers, LLC 0.00% No change 600 $0

"% of holder's portfolio" is OCEA's weight in each manager's 13F, not the share of Ocean Biomedical Inc. the manager owns.